The Influence of Diabetic Peripheral Neuropathy on the Duration of Sciatic Nerve Block with 1.3% Liposomal Bupivacaine and 0.25% Bupivacaine Hydrochloride in a Mouse Model
Open Access
- 30 August 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (9) , 1824
Abstract
Little is known regarding the pharmacological properties of extended-release local anesthetics in the setting of diabetic peripheral neuropathy. We investigated and compared the duration of sciatic nerve block following administration of clinically relevant concentrations of liposomal bupivacaine (LB) and bupivacaine hydrochloride (BH) in diabetic mice with peripheral neuropathy. In this prospective, randomized, and double-blind study, twenty-four female C57BL/6J-OlaHsd mice were assigned to a streptozotocin-induced type 1 diabetes group and a control group without diabetes. The presence of peripheral neuropathy was established by assessing the duration of thermal latency of the plantar and tail-flick tests, following which both groups were subdivided into two subgroups in which 35 mg/kg of 1.31% LB and 7 mg/kg of 0.25% BH were respectively administered for sciatic nerve block. The average sensory block duration with BH was 106 min and 117.1 min in the control and diabetic groups, respectively. With LB, the average sensory block duration was 118 min in the control mice, while in mice with diabetic peripheral neuropathy, the average block duration was significantly longer and above the 270 min limit set in our study. Accordingly, sensory block duration was longer with LB compared to BH, and diabetic peripheral neuropathy significantly increased sciatic nerve block duration with LB.Keywords
Funding Information
- The Slovenian Research and Innovation Agency (P3-0043, P4-0220)
- Clinical Department of Anaesthesiology and Intensive Therapy (P3-0043, P4-0220)
- University Clinical Centre Ljubljana, Slovenia (P3-0043, P4-0220)
This publication has 84 references indexed in Scilit:
- NHS Diabetes guideline for the perioperative management of the adult patient with diabetes*Diabetic Medicine, 2012
- Sensory Neurons Derived from Diabetic Rats Have Diminished Internal Ca 2+ Stores Linked to Impaired Re-uptake by the Endoplasmic ReticulumASN Neuro, 2012
- The Safety of EXPAREL ® (Bupivacaine Liposome Injectable Suspension) Administered by Peripheral Nerve Block in Rabbits and DogsJournal of Drug Delivery, 2012
- Local Anesthetic Schwann Cell Toxicity Is Time and Concentration DependentRegional Anesthesia & Pain Medicine, 2011
- GLP‐1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic miceDiabetes, Obesity and Metabolism, 2011
- Short‐term metabolic change is associated with improvement in measures of diabetic neuropathy: a 1‐year placebo cohort analysisDiabetic Medicine, 2010
- Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic miceNeuroscience Letters, 2008
- Liposomal formulations of prilocaine, lidocaine and mepivacaine prolong analgesic durationCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2006
- The Electrophysiologic Profile of Diabetic NeuropathySeminars in Neurology, 1996
- Tail immersion test for the evaluation of a nociceptive reaction in miceJournal of Pharmacological Methods, 1989